Loading organizations...
Key people at HERAN Partners.
HERAN Partners is a Belgian venture capital and investment fund that provides seed and early-stage capital to European HealthTech and MedTech companies, based in Antwerp, Belgium. The firm actively invests in technology-focused startups and scale-ups across the European HealthTech, MedTech, and Digital Health sectors, offering venture and growth capital. Beyond funding, HERAN Partners provides mentorship, expertise, and network support to its portfolio companies, aiming to accelerate their development and market penetration. The firm manages dedicated HealthTech funds, including Heran HealthTech Fund I and Heran HealthTech Fund II, targeting companies with robust technology platforms and significant market potential. Its leadership team includes Investment Director Geoffrey D'hondt and investor and coach Mercedes Tuin. HERAN Partners was established in 2020 by co-founders Annie Vereecken, Katleen Vandersmissen, Joris Mortelmans, and Herman Verrelst.
Key people at HERAN Partners.
HERAN Partners has 2 tracked investments across 2 companies. The latest tracked deal is $5.9M Seed in Nuclivision in April 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 24, 2025 | Nuclivision | $5.9M Seed | Heran Partners, Lumo Labs | — |
| Jun 21, 2022 | LynxCare | $21.1M Series A | Christoph Kausch | Btov Partners, Elaia, PMV |